These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7947080)

  • 1. Detection of the anti-p53 antibody response in malignant and benign pancreatic disease.
    Marxsen J; Schmiegel W; Röder C; Harder R; Juhl H; Henne-Bruns D; Kremer B; Kalthoff H
    Br J Cancer; 1994 Nov; 70(5):1031-4. PubMed ID: 7947080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of anti-p53-autoantibodies in pancreatic disorders.
    Gansauge S; Gansauge F; Negri G; Galle P; Müller J; Nüssler AK; Poch B; Beger HG
    Int J Pancreatol; 1996 Jun; 19(3):171-8. PubMed ID: 8807362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 autoantibodies in patients with pancreatitis and pancreatic carcinoma.
    Raedle J; Oremek G; Welker M; Roth WK; Caspary WF; Zeuzem S
    Pancreas; 1996 Oct; 13(3):241-6. PubMed ID: 8884844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implications of p53 alterations and anti-p53 antibody response in head and neck squamous cell carcinomas.
    Lavieille JP; Righini C; Reyt E; Brambilla C; Riva C
    Oral Oncol; 1998 Mar; 34(2):84-92. PubMed ID: 9682769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical implication of anti-p53 antibodies and p53-protein in pancreatic disease.
    Ohshio G; Suwa H; Imamura M
    Int J Gastrointest Cancer; 2002; 31(1-3):129-35. PubMed ID: 12622424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Detection of serum anti-p53 antibodies in patients with various types of cancer].
    Sakai H
    Rinsho Byori; 2002 Jan; 50(1):90-2. PubMed ID: 11871143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies against p53 protein in serum of patients with benign or malignant pancreatic and biliary diseases.
    Laurent-Puig P; Lubin R; Semhoun-Ducloux S; Pelletier G; Fourre C; Ducreux M; Briantais MJ; Buffet C; Soussi T
    Gut; 1995 Mar; 36(3):455-8. PubMed ID: 7698709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-p53 and anti-heat shock proteins antibodies in patients with malignant or pre-malignant lesions of the oral cavity.
    Castelli M; Cianfriglia F; Manieri A; Palma L; Pezzuto RW; Falasca G; Delpino A
    Anticancer Res; 2001; 21(1B):753-8. PubMed ID: 11299839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The presence of anti-p53 antibodies in sera from patients with oesophageal carcinoma: correlation to treatment, tumour volume and survival.
    Bergström S; Dreilich M; Wagenius G; Brattström D; Larsson A; Hesselius P; Bergqvist M
    In Vivo; 2004; 18(5):615-20. PubMed ID: 15523902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement and evaluation of serum anti-p53 antibody levels in patients with lung cancer at its initial presentation: a prospective study.
    Segawa Y; Kageyama M; Suzuki S; Jinno K; Takigawa N; Fujimoto N; Hotta K; Eguchi K
    Br J Cancer; 1998 Sep; 78(5):667-72. PubMed ID: 9744508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of specific ELISA for the detection of antibodies directed against p53 protein in patients with hepatocellular carcinoma.
    Ryder SD; Rizzi PM; Volkmann M; Metivier E; Pereira LM; Galle PR; Naoumov NV; Zentgraf H; Williams R
    J Clin Pathol; 1996 Apr; 49(4):295-9. PubMed ID: 8655704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 autoantibodies in patients with malignant mesothelioma: stability through disease progression.
    Creaney J; McLaren BM; Stevenson S; Musk AW; de Klerk N; Robinson BW; Lake RA
    Br J Cancer; 2001 Jan; 84(1):52-6. PubMed ID: 11139313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The detection of serum anti-p53 antibodies from patients with gastric carcinoma in China.
    Qiu LL; Hua PY; Ye LL; Wang YC; Qiu T; Bao HZ; Wang L
    Cancer Detect Prev; 2007; 31(1):45-9. PubMed ID: 17292563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum p53 antibodies as early markers of lung cancer.
    Lubin R; Zalcman G; Bouchet L; Trédanel J; Legros Y; Cazals D; Hirsch A; Soussi T
    Nat Med; 1995 Jul; 1(7):701-2. PubMed ID: 7585154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlations between p53-protein accumulation, serum antibodies and gene mutation in colorectal cancer.
    Hammel P; Leroy-Viard K; Chaumette MT; Villaudy J; Falzone MC; Rouillard D; Hamelin R; Boissier B; Remvikos Y
    Int J Cancer; 1999 May; 81(5):712-8. PubMed ID: 10328221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of serum anti-P53 antibodies from patients with colorectal cancer in China using a combination of P53- and phage-ELISA: correlation to clinical parameters.
    Wu J; Qiu T; Pan P; Yu D; Ju Z; Qu X; Gao X; Mao C; Wang L
    Asian Pac J Cancer Prev; 2011; 12(11):2921-4. PubMed ID: 22393964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation.
    Winter SF; Minna JD; Johnson BE; Takahashi T; Gazdar AF; Carbone DP
    Cancer Res; 1992 Aug; 52(15):4168-74. PubMed ID: 1322237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of p53 antibody response in patients with squamous cell carcinoma of the head and neck.
    Lavieille JP; Lubin R; Soussi T; Reyt E; Brambilla C; Riva C
    Anticancer Res; 1996; 16(4C):2385-8. PubMed ID: 8816839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of anti-p53 antibodies by ELISA using p53 synthetic or phage-displayed peptides.
    Portefaix JM; Fanutti C; Granier C; Crapez E; Perham R; Grenier J; Pau B; Del Rio M
    J Immunol Methods; 2002 Jan; 259(1-2):65-75. PubMed ID: 11730842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Divergence between the high rate of p53 mutations in skin carcinomas and the low prevalence of anti-p53 antibodies.
    Moch C; Moysan A; Lubin R; de la Salmonière P; Soufir N; Galisson F; Vilmer C; Venutolo E; Le Pelletier F; Janin A; Basset-Séguin N
    Br J Cancer; 2001 Dec; 85(12):1883-6. PubMed ID: 11747330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.